List of insiders holdings for Zentalis Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 2023-06-20 16:30:54 | 0 13,959,973 | 13,959,973 | Form 4 |
| Recurium Equity LLC 10% Owner | 2020-10-30 19:53:12 | 4,162,930 0 | 4,162,930 | Form 4 |
| EASTLAND JULIA MARIE CEO & President | 2024-12-03 19:02:15 | 3,028,800 0 | 3,028,800 | Form 4 |
| VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 2022-02-14 17:01:24 | 2,118,284 0 | 2,118,284 | Form 13G |
| Bunker Kevin D. Chief Scientific Officer | 2023-12-21 17:47:53 | 834,931 15,350 | 850,281 | Form 4 |
| Blackwell Kimberly Chief Executive Officer | 2024-02-05 19:11:29 | 734,145 0 | 734,145 | Form 4 |
| Bruns Ingmar Chief Medical Officer | 2024-12-03 19:02:41 | 712,650 0 | 712,650 | Form 4 |
| Gallagher Cam President, Interim CFO | 2024-05-31 18:27:15 | 633,680 0 | 633,680 | Form 4 |
| Epperly Melissa B Chief Financial Officer | 2024-02-12 20:22:44 | 451,449 0 | 451,449 | Form 4 |
| HAUSMAN DIANA Chief Medical Officer | 2024-05-09 19:46:59 | 373,876 0 | 373,876 | Form 4 |
| SUN ANTHONY Y President & CEO | 2023-03-09 19:16:00 | 360,542 0 | 360,542 | Form 13G |
| Paul Andrea Chief Legal Officer | 2024-02-05 19:14:48 | 352,473 0 | 352,473 | Form 4 |
| Roth Iris Chief Operating Officer | 2023-03-02 16:30:11 | 350,000 0 | 350,000 | Form 4 |
| Lackner Mark Chief Scientific Officer | 2024-02-05 19:15:34 | 336,728 0 | 336,728 | Form 4 |
| Myers Scott Dunseth Director | 2024-11-13 17:46:58 | 260,192 0 | 260,192 | Form 4 |
| Johnson David Michael Director | 2024-06-21 17:07:33 | 192,818 0 | 192,818 | Form 4 |
| Brownstein Carrie Chief Medical Officer | 2023-10-06 19:19:49 | 105,685 0 | 105,685 | Form 4 |
| Skvarka Jan Director | 2024-06-21 17:11:02 | 89,551 0 | 89,551 | Form 4 |
| Kariuki Enoch Director | 2024-06-21 17:09:42 | 79,762 0 | 79,762 | Form 4 |
| Walker Luke Nathaniel Director | 2024-05-29 07:34:11 | 72,481 0 | 72,481 | Form 4 |
| Pinto Alexis Chief Legal Officer | 2022-02-14 21:10:22 | 60,729 0 | 60,729 | Form 4 |
| Voliotis Dimitris SVP, Clinical Development | 2022-02-14 21:10:45 | 40,212 0 | 40,212 | Form 4 |
| Vultaggio Vincent Principal Accounting Officer | 2024-10-04 18:01:21 | 33,855 0 | 33,855 | Form 4 |
| Takhar Karan S. Director | 2020-04-03 17:59:21 | 0 0 | 0 | Form 3 |